Specifica is a biotechnology company specializing in the development and optimization of antibody discovery technologies. They focus on creating high-quality, fully human antibody libraries and providing advanced platforms for antibody selection and engineering. Specifica's offerings include their proprietary Generation 3 Antibody Libraries, which are designed to produce diverse and high-affinity antibodies for therapeutic and diagnostic applications. They also provide custom library construction, antibody discovery services, and consulting to help clients accelerate their drug development programs. Specifica aims to enhance the efficiency and success rate of antibody discovery and development, supporting the creation of novel biologics for various diseases.
Resource type
Material
Country
United States
Access requirements
Purchase